marketcaparena
Search

    INVA

    Innoviva, Inc.

    Company overview

    Market capitalization
    $1.53B
    Employees
    159
    Latest publication
    2026-09-29
    About Innoviva, Inc.

    Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally. Its royalty portfolio includes RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol, and an inhaled corticosteroid, and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, and ABA, VI. The company also markets GIAPREZA for increasing blood pressure in adults with septic or other distributive shock; XACDURO, a co-packaged for intravenous use for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia caused by Acinetobacter; XERAVA for the treatment of complicated intra-abdominal infections in adults; ZEVTERA an advanced-generation cephalosporin antibiotic for the treatment of staphylococcus aureus bacteremia, as well as with right-sided endocarditis, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia; NUZOLVENCE for the treatment of uncomplicated urogenital gonorrhea in adults and adolescents. In addition, the company develops bacteriophages with potential use in a range of infectious and other serious diseases. It has a strategic partnership with Sarissa Capital Management LP; and LABA Collaboration Agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Total Revenue119,591,000USD97,994,000USD118,045,000USD107,800,000USD91,806,000USD89,508,000USD103,354,000USD77,499,000USD
    Cost Of Revenue22,349,000USD22,161,000USD42,433,000USD25,776,000USD7,165,000USD9,990,000USD18,388,000USD10,971,000USD
    Gross Profit90,616,000USD75,833,000USD75,612,000USD82,024,000USD84,641,000USD79,518,000USD84,966,000USD66,528,000USD
    Research Development5,190,000USD5,241,000USD4,555,000USD13,670,000USD3,665,000USD3,551,000USD2,560,000USD3,878,000USD
    Selling General Administrative34,571,000USD32,438,000USD32,124,000USD27,291,000USD31,326,000USD26,219,000USD27,740,000USD30,405,000USD
    Total Operating Expenses39,761,000USD37,679,000USD36,624,000USD47,446,000USD41,502,000USD29,770,000USD30,280,000USD40,723,000USD
    Operating Income50,855,000USD38,154,000USD38,988,000USD34,578,000USD43,139,000USD49,748,000USD54,686,000USD25,805,000USD
    Total Other Income Expense Net-158,875,000USD196,409,000USD156,048,000USD63,239,000USD-18,445,000USD-42,899,000USD-93,965,000USD19,319,000USD
    Interest Income7,599,000USD10,987,000USD6,151,000USD5,472,000USD5,768,000USD5,500,000USD3,474,000USD4,399,000USD
    Interest Expense5,472,000USD5,437,000USD3,309,000USD4,015,000USD4,749,000USD5,807,000USD5,802,000USD5,851,000USD
    Income Before Tax-108,020,000USD234,563,000USD195,036,000USD97,817,000USD24,694,000USD6,849,000USD-39,279,000USD45,124,000USD
    Income Tax Expense-24,600,000USD47,968,000USD30,883,000USD7,909,000USD4,362,000USD5,636,000USD-4,594,000USD8,592,000USD
    Equity Method Income Loss-131,834,000USD———————
    Net Income-83,420,000USD186,595,000USD164,153,000USD89,908,000USD20,332,000USD1,213,000USD-34,685,000USD36,532,000USD
    Net Interest Income—5,550,000USD2,842,000USD1,457,000USD1,019,000USD-307,000USD-2,328,000USD-1,452,000USD
    Tax Provision—47,968,000USD30,883,000USD7,909,000USD4,362,000USD5,636,000USD-4,594,000USD8,592,000USD
    Net Income From Continuing Ops—186,595,000USD164,153,000USD89,908,000USD20,332,000USD1,213,000USD-34,685,000USD36,532,000USD
    Ebit—229,126,000USD198,345,000USD101,832,000USD29,443,000USD12,656,000USD-33,477,000USD50,975,000USD
    Ebitda—239,167,000USD208,469,000USD108,482,000USD35,954,000USD19,167,000USD-23,561,000USD57,415,000USD
    Depreciation And Amortization—10,041,000USD10,124,000USD6,650,000USD6,511,000USD6,511,000USD9,916,000USD6,440,000USD
    Reconciled Depreciation—6,554,000USD6,637,000USD6,618,000USD6,511,000USD6,511,000USD6,440,000USD6,440,000USD
    Unclassified Operating Expenses———6,485,000USD6,511,000USD——6,440,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20112011-12-31 · USDFY 20082008-12-31 · USDFY 20042004-12-31 · USD
    Total Revenue425,128,000USD358,711,000USD310,463,000USD217,217,000USD133,569,000USD24,512,000USD23,096,000USD8,940,000USD
    Cost Of Revenue117,612,000USD36,598,000USD42,640,000USD1,355,000USD1,393,000USD130,449,000USD106,381,000USD110,523,000USD
    Gross Profit307,516,000USD322,113,000USD267,823,000USD217,217,000USD132,176,000USD24,512,000USD23,096,000USD8,940,000USD
    Research Development30,604,000USD13,654,000USD33,922,000USD1,355,000USD1,393,000USD103,568,000USD82,020,000USD86,996,000USD
    Selling General Administrative113,318,000USD115,690,000USD89,367,000USD32,258,000USD23,188,000USD30,681,000USD28,861,000USD28,339,000USD
    Total Operating Expenses143,771,000USD155,246,000USD153,938,000USD33,613,000USD23,187,999USD134,249,000USD110,881,000USD112,335,000USD
    Operating Income163,745,000USD166,867,000USD113,885,000USD183,604,000USD108,988,000USD-109,737,000USD-87,785,000USD-102,395,000USD
    Interest Income21,086,000USD19,141,000USD14,220,000USD1,311,000USD582,000USD———
    Interest Expense16,698,000USD22,209,000USD19,157,000USD43,601,000USD52,416,000USD6,022,000USD5,681,000USD823,000USD
    Net Interest Income4,388,000USD-3,068,000USD-3,013,000USD-42,290,000USD-51,834,000USD———
    Income Before Tax326,862,000USD37,388,000USD194,098,000USD134,272,000USD59,536,000USD-115,344,000USD-93,643,000USD-102,654,000USD
    Income Tax Expense55,697,000USD13,996,000USD14,376,000USD4,000USD95,000USD415,000USD439,000USD-741,000USD
    Tax Provision55,697,000USD13,996,000USD18,332,000USD—————
    Net Income271,165,000USD23,392,000USD179,722,000USD134,143,000USD59,536,000USD-115,344,000USD-93,643,000USD-102,654,000USD
    Net Income From Continuing Ops271,165,000USD23,392,000USD49,877,000USD134,272,000USD59,536,000USD-115,344,000USD——
    Ebit343,560,000USD59,597,000USD213,255,000USD177,744,000USD108,988,000USD-109,322,000USD-87,962,000USD-101,831,000USD
    Ebitda383,788,000USD85,499,000USD235,039,000USD191,726,000USD122,942,000USD-101,739,000USD-81,000,000USD-97,019,000USD
    Depreciation And Amortization40,228,000USD25,902,000USD21,784,000USD13,982,000USD13,954,000USD7,583,000USD6,962,000USD4,812,000USD
    Reconciled Depreciation26,277,000USD25,902,000USD33,265,000USD13,982,000USD————
    Total Other Income Expense Net163,117,000USD-129,479,000USD80,213,000USD-49,332,000USD-49,452,000USD-5,607,000USD-5,858,000USD-259,000USD
    Unclassified Operating Expenses—25,902,000USD30,649,000USD—-1,393,001USD——-3,000,000USD
    Minority Interest—0USD0USD129,000USD————
    Non Operating Income Net Other———-5,731,000USD2,964,000USD415,000USD——
    Net Income Applicable To Common Shares———134,143,000USD59,536,000USD-115,344,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,702,727,000USD1,836,587,000USD1,635,165,000USD1,429,106,000USD1,333,572,000USD1,254,390,000USD1,301,060,000USD1,231,612,000USD
    Cash And Equivalents570,388,000USD———————
    Long Term Investments441,308,000USD764,454,000USD598,223,000USD426,371,000USD349,110,000USD329,844,000USD393,957,000USD507,718,000USD
    Total Current Assets753,366,000USD772,623,000USD727,515,000USD684,570,000USD651,778,000USD582,022,000USD554,306,000USD400,621,000USD
    Other Current Assets313,000USD29,221,000USD102,436,000USD19,586,000USD16,791,000USD15,727,000USD21,719,000USD14,697,000USD
    Other Non Current Assets39,894,000USD———————
    Total Liabilities469,465,000USD———————
    Total Current Liabilities47,064,000USD36,558,000USD49,696,000USD48,471,000USD246,563,000USD234,745,000USD236,083,000USD223,750,000USD
    Other Non Current Liabilities67,276,000USD———————
    Total Stockholder Equity1,233,262,000USD1,341,655,000USD1,172,841,000USD1,009,951,000USD714,821,000USD646,905,000USD691,159,000USD668,542,000USD
    Total Equity Including Noncontrolling Interest1,233,262,000USD———————
    Long Term Debt258,454,000USD258,095,000USD257,731,000USD257,377,000USD257,019,000USD256,670,000USD256,316,000USD255,972,000USD
    Deferred Revenue6,015,000USD———————
    Inventory38,968,000USD38,843,000USD39,172,000USD38,363,000USD48,996,000USD41,479,000USD33,725,000USD34,236,000USD
    Property Plant Equipment Net12,510,000USD12,794,000USD12,484,000USD2,931,000USD2,210,000USD2,593,000USD2,967,000USD3,333,000USD
    Goodwill17,905,000USD———————
    Intangible Assets168,976,000USD175,602,000USD182,156,000USD186,193,000USD195,411,000USD201,958,000USD208,433,000USD210,944,000USD
    Accounts Payable4,016,000USD6,518,000USD4,966,000USD6,243,000USD5,382,000USD4,700,000USD2,132,000USD4,170,000USD
    Common Stock727,000USD738,000USD747,000USD748,000USD630,000USD628,000USD627,000USD626,000USD
    Retained Earnings372,543,000USD455,963,000USD269,368,000USD105,215,000USD15,307,000USD-48,381,000USD-1,797,000USD-22,129,000USD
    Total Liab—494,932,000USD462,324,000USD419,155,000USD618,751,000USD607,485,000USD609,901,000USD563,070,000USD
    Other Current Liab—-37,321,000USD39,768,000USD33,806,000USD45,170,000USD34,006,000USD39,225,000USD22,886,000USD
    Capital Stock—738,000USD747,000USD748,000USD630,000USD628,000USD627,000USD626,000USD
    Good Will—17,905,000USD17,905,000USD17,905,000USD17,905,000USD17,905,000USD17,905,000USD17,905,000USD
    Other Assets—988,358,000USD————215,617,000USD—
    Cash—603,085,000USD550,941,000USD476,513,000USD397,532,000USD319,090,000USD304,964,000USD260,630,000USD
    Cash And Short Term Investments—611,931,000USD550,941,000USD533,102,000USD497,730,000USD446,880,000USD412,496,000USD260,630,000USD
    Current Deferred Revenue—3,677,000USD4,270,000USD13,571,000USD3,125,000USD1,002,000USD1,126,000USD717,000USD
    Net Debt—-271,667,000USD-281,924,000USD-153,283,000USD53,373,000USD132,166,000USD146,131,000USD190,281,000USD
    Short Term Debt—5,339,000USD418,000USD8,422,000USD192,886,000USD193,495,000USD193,600,000USD193,354,000USD
    Short Long Term Debt Total—331,418,000USD269,017,000USD323,230,000USD450,905,000USD451,256,000USD451,095,000USD450,911,000USD
    Short Term Investments—8,846,000USD15,727,000USD56,589,000USD100,198,000USD127,790,000USD107,532,000USD—
    Net Receivables—92,628,000USD34,966,000USD93,519,000USD88,261,000USD77,936,000USD86,366,000USD91,058,000USD
    Property Plant Equipment Gross—12,794,000USD12,484,000USD2,931,000USD2,210,000USD2,593,000USD2,967,000USD3,333,000USD
    Common Stock Shares Outstanding—84,849,000shares85,264,000shares84,964,000shares84,452,000shares62,709,000shares84,200,000shares62,951,000shares
    Non Current Assets Total—1,063,964,000USD907,650,000USD744,536,000USD681,794,000USD672,368,000USD746,754,000USD830,991,000USD
    Non Current Liabilities Total—458,374,000USD412,628,000USD370,684,000USD372,188,000USD372,740,000USD373,818,000USD339,320,000USD
    Non Current Liabilities Other—1,119,000USD1,119,000USD—————
    Non Currrent Assets Other—93,209,000USD501,379,000USD111,136,000USD104,227,000USD107,774,000USD111,438,000USD76,216,000USD
    Net Working Capital—736,065,000USD677,819,000USD636,099,000USD405,215,000USD347,277,000USD318,223,000USD176,871,000USD
    Unclassified Non Current Assets—-988,358,000USD-404,497,000USD—12,931,000USD12,294,000USD-203,563,000USD14,875,000USD
    Unclassified Current Liabilities—21,024,000USD—-13,571,000USD-191,903,000USD-190,673,000USD-192,028,000USD-189,220,000USD
    Unclassified Non Current Liabilities—199,160,000USD153,778,000USD113,307,000USD115,169,000USD116,070,000USD117,502,000USD83,348,000USD
    Unclassified Equity—884,216,000USD901,979,000USD903,240,000USD698,254,000USD694,030,000USD691,702,000USD689,419,000USD
    Unclassified Current Assets——-15,727,000USD—————
    Accumulated Other Comprehensive Income———0USD————
    Short Long Term Debt————191,903,000USD192,215,000USD192,028,000USD191,843,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,635,165,000USD1,301,060,000USD1,243,507,000USD1,231,497,000USD926,395,000USD999,570,000USD724,826,000USD548,193,000USD
    Intangible Assets182,156,000USD208,433,000USD230,335,000USD252,919,000USD10,256,000USD93,931,000USD139,076,000USD152,899,000USD
    Other Current Assets102,436,000USD21,719,000USD25,894,000USD32,492,000USD1,437,000USD95,571,000USD962,000USD849,000USD
    Total Liab462,324,000USD609,901,000USD568,552,000USD665,709,000USD400,460,000USD391,733,000USD382,710,000USD389,141,000USD
    Total Stockholder Equity1,172,841,000USD691,159,000USD674,955,000USD565,788,000USD414,742,999USD607,837,000USD313,495,000USD153,583,000USD
    Other Current Liab39,768,000USD-14,002,000USD17,182,000USD32,272,000USD5,674,000USD6,044,000USD5,361,000USD5,689,000USD
    Common Stock747,000USD627,000USD633,000USD692,000USD696,000USD1,014,000USD1,013,000USD1,011,000USD
    Capital Stock747,000USD627,000USD633,000USD692,000USD696,000USD1,014,000USD1,013,000USD1,011,000USD
    Retained Earnings269,368,000USD-1,797,000USD-25,189,000USD-204,911,000USD-456,148,000USD-722,002,000USD-946,404,000USD-1,103,692,000USD
    Good Will17,905,000USD17,905,000USD17,905,000USD26,713,000USD101,174,000USD———
    Cash550,941,000USD304,964,000USD193,513,000USD291,049,000USD201,525,000USD246,487,000USD278,096,000USD62,417,000USD
    Cash And Short Term Investments550,941,000USD412,496,000USD193,513,000USD291,049,000USD201,525,000USD246,487,000USD350,845,000USD114,908,000USD
    Total Current Assets727,515,000USD554,306,000USD344,219,000USD443,511,000USD313,673,000USD342,058,000USD431,234,000USD199,043,000USD
    Total Current Liabilities49,696,000USD236,083,000USD38,134,000USD134,968,000USD5,807,000USD6,110,000USD5,371,000USD5,700,000USD
    Current Deferred Revenue4,270,000USD1,126,000USD1,277,000USD2,094,000USD-106,000USD———
    Net Debt-281,924,000USD146,131,000USD255,563,000USD253,016,000USD193,234,000USD139,030,000USD99,024,000USD320,438,000USD
    Short Term Debt418,000USD193,600,000USD1,207,000USD97,509,000USD106,000USD25,000,000USD——
    Short Long Term Debt Total269,017,000USD451,095,000USD449,076,000USD544,065,000USD394,759,000USD410,517,000USD377,120,000USD382,855,000USD
    Long Term Debt257,731,000USD256,316,000USD446,234,000USD540,373,000USD394,653,000USD385,517,000USD377,120,000USD382,855,000USD
    Long Term Investments598,223,000USD393,957,000USD560,978,000USD403,013,000USD483,845,000USD438,258,000USD——
    Short Term Investments15,727,000USD107,532,000USD0USD403,013,000USD483,845,000USD438,258,000USD72,749,000USD52,491,000USD
    Net Receivables34,966,000USD86,366,000USD84,075,000USD64,073,000USD110,711,000USD93,931,000USD79,427,000USD83,286,000USD
    Inventory39,172,000USD33,725,000USD40,737,000USD55,897,000USD-110,711,000USD-93,931,000USD-79,427,000USD-83,286,000USD
    Accounts Payable4,966,000USD2,132,000USD6,717,000USD2,939,000USD27,000USD66,000USD10,000USD11,000USD
    Property Plant Equipment Net12,484,000USD2,967,000USD3,019,000USD3,435,000USD109,000USD28,000USD33,000USD160,000USD
    Property Plant Equipment Gross12,484,000USD2,967,000USD3,019,000USD3,435,000USD12,000USD28,000USD33,000USD160,000USD
    Common Stock Shares Outstanding84,760,000shares74,187,000shares86,876,000shares95,249,000shares94,311,000shares113,554,000shares113,409,000shares113,408,000shares
    Non Current Assets Total907,650,000USD746,754,000USD899,288,000USD787,986,000USD612,722,000USD657,512,000USD293,592,000USD349,150,000USD
    Non Current Liabilities Total412,628,000USD373,818,000USD530,418,000USD530,741,000USD394,653,000USD385,623,000USD377,339,000USD383,441,000USD
    Non Current Liabilities Other1,119,000USD—359,000USD70,918,000USD—106,000USD219,000USD586,000USD
    Non Currrent Assets Other501,379,000USD111,438,000USD87,051,000USD101,906,000USD128,768,000USD214,000USD139,388,000USD152,936,000USD
    Net Working Capital677,819,000USD318,223,000USD306,085,000USD404,736,000USD307,866,000USD335,948,000USD425,863,000USD193,343,000USD
    Unclassified Current Assets-15,727,000USD——-403,013,000USD-483,845,000USD-532,189,000USD——
    Unclassified Non Current Assets-404,497,000USD12,054,000USD—-198,471,000USD-536,641,000USD-532,403,000USD-278,464,000USD-305,835,000USD
    Unclassified Non Current Liabilities153,778,000USD117,502,000USD83,825,000USD-262,342,000USD-111,430,000USD-125,359,000USD-139,295,000USD-153,485,000USD
    Unclassified Equity901,979,000USD691,702,000USD698,878,000USD769,315,000USD869,498,999USD1,327,811,000USD1,257,846,000USD1,255,256,000USD
    Short Long Term Debt—192,028,000USD—96,193,000USD————
    Unclassified Current Liabilities—-152,803,000USD11,751,000USD-96,039,000USD—-25,000,000USD——
    Accumulated Other Comprehensive Income——0USD—0USD0USD27,000USD-3,000USD
    Deferred Long Term Liab———97,607,000USD111,430,000USD125,253,000USD139,076,000USD152,899,000USD
    Other Liab———84,185,000USD—106,000USD219,000USD586,000USD
    Other Assets———198,471,000USD425,211,000USD657,484,000USD293,559,000USD348,990,000USD
    Net Tangible Assets———286,156,000USD414,743,000USD539,912,000USD313,495,000USD153,583,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income186,595,000USD89,908,000USD63,688,000USD-46,584,000USD20,332,000USD1,213,000USD-34,685,000USD36,532,000USD
    Depreciation10,041,000USD6,618,000USD6,547,000USD6,475,000USD6,511,000USD9,991,000USD6,440,000USD6,440,000USD
    Stock Based Compensation2,567,000USD2,380,000USD2,422,000USD2,147,000USD1,673,000USD1,603,000USD1,643,000USD1,455,000USD
    Other Non Cash Items-190,502,000USD-45,487,000USD-20,332,000USD83,920,000USD24,925,000USD37,324,000USD99,486,000USD-12,642,000USD
    Change To Account Receivables961,000USD-5,258,000USD-10,325,000USD8,430,000USD1,045,000USD2,922,000USD-17,970,000USD8,065,000USD
    Change To Inventory-1,310,000USD6,847,000USD-7,993,000USD-9,153,000USD19,420,000USD633,000USD-2,690,000USD-3,543,000USD
    Change In Working Capital-14,457,000USD-8,641,000USD-7,615,000USD2,899,000USD2,977,000USD1,984,000USD-13,913,000USD2,018,000USD
    Total Cash From Operating Activities35,282,000USD49,727,000USD44,073,000USD48,617,000USD59,239,000USD48,686,000USD43,718,000USD37,047,000USD
    Capital Expenditures-492,000USD-1,121,000USD0USD0USD-4,000,000USD-270,000USD0USD0USD
    Free Cash Flow34,790,000USD48,606,000USD44,073,000USD48,617,000USD55,239,000USD48,416,000USD43,718,000USD37,047,000USD
    Investments-3,335,000USD18,412,000USD33,122,000USD-34,674,000USD-15,478,000USD-5,270,000USD0USD-43,038,000USD
    Total Cashflows From Investing Activities37,008,000USD18,412,000USD33,122,000USD-34,674,000USD-15,478,000USD-5,270,000USD—-43,038,000USD
    Total Cash From Financing Activities-20,146,000USD10,842,000USD1,247,000USD183,000USD573,000USD211,000USD-5,072,000USD-9,165,000USD
    Sale Purchase Of Stock-20,405,000USD-25,000USD-24,000USD-67,000USD-19,000USD-18,000USD-5,229,000USD-9,653,000USD
    Issuance Of Capital Stock259,000USD194,000USD1,271,000USD250,000USD592,000USD229,000USD157,000USD488,000USD
    Change In Cash52,144,000USD78,981,000USD78,442,000USD14,126,000USD44,334,000USD43,627,000USD38,646,000USD-15,156,000USD
    Begin Period Cash Flow550,941,000USD397,532,000USD319,090,000USD304,964,000USD260,630,000USD217,003,000USD178,357,000USD193,513,000USD
    End Period Cash Flow603,085,000USD476,513,000USD397,532,000USD319,090,000USD304,964,000USD260,630,000USD217,003,000USD178,357,000USD
    Other Cashflows From Investing Activities-2,457,000USD-9,368,000USD19,939,000USD—3,000USD-21,404,000USD—98,000USD
    Other Cashflows From Financing Activities-20,146,000USD10,842,000USD———-5,270,000USD157,000USD-43,038,000USD
    Unclassified Operating Cash Flow41,038,000USD4,949,000USD——2,821,000USD-3,429,000USD-15,253,000USD3,244,000USD
    Unclassified Investing Cash Flow43,292,000USD10,489,000USD-19,939,000USD—3,997,000USD21,674,000USD——
    Unclassified Financing Cash Flow20,405,000USD—1,271,000USD——5,499,000USD—43,526,000USD
    Net Borrowings————0USD0USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income271,165,000USD23,392,000USD179,722,000USD220,262,000USD368,837,000USD293,814,000USD190,993,000USD406,328,000USD
    Depreciation40,228,000USD39,853,000USD35,705,000USD19,512,000USD13,832,000USD13,840,000USD13,874,000USD13,872,000USD
    Stock Based Compensation9,452,000USD6,374,000USD5,837,000USD7,347,000USD2,017,000USD1,698,000USD2,056,000USD3,233,000USD
    Other Non Cash Items-143,600,000USD138,622,000USD-59,809,000USD-77,267,000USD-80,432,000USD-28,497,000USD5,565,000USD12,912,000USD
    Change To Account Receivables-6,951,000USD-2,291,000USD-20,002,000USD9,794,000USD-16,780,000USD-14,504,000USD3,859,000USD-12,746,000USD
    Change To Inventory-12,919,000USD-6,808,000USD-12,004,000USD280,000USD280,000USD280,000USD-664,000USD-3,428,000USD
    Change In Working Capital-24,162,000USD-6,934,000USD-24,791,000USD6,866,000USD-16,873,000USD-14,322,000USD3,095,000USD-16,760,000USD
    Total Cash From Operating Activities196,930,000USD188,690,000USD141,064,000USD201,726,000USD363,813,000USD313,113,000USD257,458,000USD223,531,000USD
    Capital Expenditures-10,499,000USD-270,000USD-411,000USD-67,000USD-1,304,000USD-13,000USD-12,000USD-12,000USD
    Free Cash Flow186,431,000USD188,420,000USD140,653,000USD201,659,000USD362,509,000USD313,100,000USD257,446,000USD223,531,000USD
    Investments22,819,000USD-63,786,000USD-70,288,000USD-56,634,000USD43,722,000USD-314,924,000USD-17,991,000USD3,519,000USD
    Total Cashflows From Investing Activities40,496,000USD-63,786,000USD-66,761,000USD-56,634,000USD43,722,000USD-314,937,000USD-18,003,000USD3,519,000USD
    Net Borrowings0USD0USD-96,204,000USD87,405,000USD87,405,000USD87,405,000USD-13,750,000USD-230,000,000USD
    Total Cash From Financing Activities8,551,000USD-13,453,000USD-171,839,000USD-55,568,000USD-452,497,000USD-29,785,000USD-23,776,000USD-237,969,000USD
    Sale Purchase Of Stock-4,675,000USD-14,919,000USD-75,805,000USD-8,585,000USD-394,209,000USD-92,000USD-89,000USD-3,073,000USD
    Issuance Of Capital Stock2,553,000USD1,466,000USD139,000USD370,000USD1,169,000USD436,000USD627,000USD1,139,000USD
    Change In Cash245,977,000USD111,451,000USD-97,536,000USD89,524,000USD-44,962,000USD-31,609,000USD215,679,000USD-10,919,000USD
    Begin Period Cash Flow304,964,000USD193,513,000USD291,049,000USD201,525,000USD246,487,000USD278,096,000USD62,417,000USD73,336,000USD
    End Period Cash Flow550,941,000USD304,964,000USD193,513,000USD291,049,000USD201,525,000USD246,487,000USD278,096,000USD62,417,000USD
    Other Cashflows From Investing Activities-9,356,000USD-3,899,000USD1USD-56,634,000USD-20,978,000USD-314,924,000USD-17,991,000USD3,519,000USD
    Other Cashflows From Financing Activities8,551,000USD-13,453,000USD-66,760,999USD-113,721,000USD-59,457,000USD-30,129,000USD-10,553,000USD-5,955,000USD
    Unclassified Operating Cash Flow43,847,000USD-12,617,000USD4,400,000USD25,006,000USD76,432,000USD46,580,000USD41,875,000USD-196,054,000USD
    Unclassified Investing Cash Flow37,532,000USD4,169,000USD3,937,999USD56,701,000USD22,282,000USD314,924,000USD17,991,000USD-3,507,000USD
    Unclassified Financing Cash Flow4,675,000USD14,919,000USD163,211,999USD-20,667,000USD-86,236,000USD-86,969,000USD——
    Dividends Paid——-96,281,000USD—0USD0USD-11,000USD-80,000USD
    Change To Liabilities———-663,000USD-39,000USD860,000USD-1,000USD-3,919,000USD
    Cash And Cash Equivalents Changes————-44,962,000USD-31,609,000USD—-10,919,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductGiapreza22,299,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductLicense And Other Revenue11,486,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductRoyalty56,334,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductXacduro22,382,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductXerava6,739,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductZEVTERA351,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductGiapreza20,231,000USD0001193125-26-209110
    Q1 2026Quarterly · 2026-03-31ProductLicense And Other Revenue1,456,000USD0001193125-26-209110
    Q1 2026Quarterly · 2026-03-31ProductRoyalty55,167,000USD0001193125-26-209110
    Q1 2026Quarterly · 2026-03-31ProductXacduro18,074,000USD0001193125-26-209110
    Q1 2026Quarterly · 2026-03-31ProductXerava2,628,000USD0001193125-26-209110
    Q1 2026Quarterly · 2026-03-31ProductZEVTERA438,000USD0001193125-26-209110
    Q4 2025Quarterly · 2025-12-31ProductGiapreza19,550,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductLicense And Other Revenue653,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductRoyalty54,896,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductXacduro32,066,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductXerava7,290,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductZEVTERA158,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductGiapreza73,611,000USD0001193125-26-071776
    FY 2025Yearly · 2025-12-31ProductLicense And Other Revenue2,719,000USD0001193125-26-071776
    FY 2025Yearly · 2025-12-31ProductRoyalty236,479,000USD0001193125-26-071776
    FY 2025Yearly · 2025-12-31ProductXacduro74,393,000USD0001193125-26-071776
    FY 2025Yearly · 2025-12-31ProductXerava23,516,000USD0001193125-26-071776
    FY 2025Yearly · 2025-12-31ProductZEVTERA610,000USD0001193125-26-071776
    Q3 2025Quarterly · 2025-09-30ProductGiapreza18,459,000USD0001193125-25-267040
    Q3 2025Quarterly · 2025-09-30ProductLicense And Other Revenue610,000USD0001193125-25-267040
    Q3 2025Quarterly · 2025-09-30ProductRoyalty59,896,000USD0001193125-25-267040
    Q3 2025Quarterly · 2025-09-30ProductXacduro23,813,000USD0001193125-25-267040
    Q3 2025Quarterly · 2025-09-30ProductXerava4,909,000USD0001193125-25-267040
    Q3 2025Quarterly · 2025-09-30ProductZEVTERA113,000USD0001193125-25-267040
    Q2 2025Quarterly · 2025-06-30ProductGiapreza17,329,000USD0000950170-25-104126
    Q2 2025Quarterly · 2025-06-30ProductLicense And Other Revenue910,000USD0000950170-25-104126
    Q2 2025Quarterly · 2025-06-30ProductRoyalty63,880,000USD0000950170-25-104126
    Q2 2025Quarterly · 2025-06-30ProductXacduro10,731,000USD0000950170-25-104126
    Q2 2025Quarterly · 2025-06-30ProductXerava7,094,000USD0000950170-25-104126
    Q2 2025Quarterly · 2025-06-30ProductZEVTERA339,000USD0000950170-25-104126
    Q1 2025Quarterly · 2025-03-31ProductGiapreza18,273,000USD0001193125-26-209110
    Q1 2025Quarterly · 2025-03-31ProductLicense And Other Revenue546,000USD0001193125-26-209110
    Q1 2025Quarterly · 2025-03-31ProductRoyalty57,807,000USD0001193125-26-209110
    Q1 2025Quarterly · 2025-03-31ProductXacduro7,783,000USD0001193125-26-209110
    Q1 2025Quarterly · 2025-03-31ProductXerava4,223,000USD0001193125-26-209110
    Q1 2025Quarterly · 2025-03-31ProductZEVTERA0USD0001193125-26-209110
    Q4 2024Quarterly · 2024-12-31ProductGiapreza16,072,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductLicense And Other Revenue351,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductRoyalty62,520,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductXacduro6,708,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductXerava6,155,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductGiapreza55,037,000USD0001193125-26-071776
    FY 2024Yearly · 2024-12-31ProductLicense And Other Revenue19,486,000USD0001193125-26-071776
    FY 2024Yearly · 2024-12-31ProductRoyalty241,733,000USD0001193125-26-071776
    FY 2024Yearly · 2024-12-31ProductXacduro21,070,000USD0001193125-26-071776
    FY 2024Yearly · 2024-12-31ProductXerava21,385,000USD0001193125-26-071776
    FY 2024Yearly · 2024-12-31ProductZEVTERA0USD0001193125-26-071776
    Q3 2024Quarterly · 2024-09-30ProductGiapreza13,775,000USD0001193125-25-267040
    Q3 2024Quarterly · 2024-09-30ProductLicense And Other Revenue4,630,000USD0001193125-25-267040
    Q3 2024Quarterly · 2024-09-30ProductRoyalty57,056,000USD0001193125-25-267040
    Q3 2024Quarterly · 2024-09-30ProductXacduro9,783,000USD0001193125-25-267040
    Q3 2024Quarterly · 2024-09-30ProductXerava4,264,000USD0001193125-25-267040
    Q3 2024Quarterly · 2024-09-30ProductZEVTERA0USD0001193125-25-267040
    FY 2023Yearly · 2023-12-31ProductGiapreza41,294,000USD0001193125-26-071776
    FY 2023Yearly · 2023-12-31ProductLicense And Other Revenue11,000,000USD0001193125-26-071776
    FY 2023Yearly · 2023-12-31ProductRoyalty238,846,000USD0001193125-26-071776
    FY 2023Yearly · 2023-12-31ProductXacduro2,003,000USD0001193125-26-071776
    FY 2023Yearly · 2023-12-31ProductXerava17,320,000USD0001193125-26-071776
    FY 2023Yearly · 2023-12-31ProductZEVTERA0USD0001193125-26-071776
    FY 2022Yearly · 2022-12-31ProductGiapreza14,214,000USD0000950170-25-027864
    FY 2022Yearly · 2022-12-31ProductLicense And Other Revenue0USD0000950170-25-027864
    FY 2022Yearly · 2022-12-31ProductRoyalty311,645,000USD0000950170-25-027864
    FY 2022Yearly · 2022-12-31ProductXacduro0USD0000950170-25-027864
    FY 2022Yearly · 2022-12-31ProductXerava5,480,000USD0000950170-25-027864
    FY 2021Yearly · 2021-12-31ProductLicense Revenue0USD0000950170-24-023237
    FY 2021Yearly · 2021-12-31ProductProduct0USD0000950170-24-023237
    FY 2021Yearly · 2021-12-31ProductRoyalty391,866,000USD0000950170-24-023237
    FY 2020Yearly · 2020-12-31ProductCollaborative Arrangements10,000,000USD0000950170-23-005168
    FY 2020Yearly · 2020-12-31ProductProduct0USD0000950170-23-005168
    FY 2020Yearly · 2020-12-31ProductRoyalty326,794,000USD0000950170-23-005168
    FY 2019Yearly · 2019-12-31ProductCollaborative Arrangements0USD0000950170-22-002169
    FY 2019Yearly · 2019-12-31ProductRoyalty261,016,000USD0000950170-22-002169
    FY 2018Yearly · 2018-12-31ProductCollaborative Arrangements0USD0001104659-21-028328
    FY 2018Yearly · 2018-12-31ProductRoyalty261,004,000USD0001104659-21-028328
    Q3 2013Quarterly · 2013-07-31SegmentDesert Communications Inc7,230,809USD0001214659-13-005255
    Q3 2013Quarterly · 2013-07-31SegmentTrakkers LLCRight Tag Inc379,905USD0001214659-13-005255
    FY 2013Yearly · 2013-04-30SegmentDCI17,486,102USD0001214659-13-004345
    FY 2013Yearly · 2013-04-30SegmentRFID1,194,888USD0001214659-13-004345
    FY 2012Yearly · 2012-04-30SegmentDCI19,565,451USD0001214659-13-004345
    FY 2012Yearly · 2012-04-30SegmentRFID1,642,242USD0001214659-13-004345

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.